Seroatlas · Human Serome Atlas

TFAM

Transcription factor A, mitochondrial

Also known as: TCF6, TCF6L2, TFAM_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q00059
Gene
TFAM
Ensembl
ENSG00000108064
Chromosome
10
Canonical length
246 aa
Protein class
Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
Subcellular location
Mitochondria
Quaternary structure
Homodimer

OverviewNCBI Gene

This gene encodes a key mitochondrial transcription factor containing two high mobility group motifs. The encoded protein also functions in mitochondrial DNA replication and repair. Sequence polymorphisms in this gene are associated with Alzheimer's and Parkinson's diseases. There are pseudogenes for this gene on chromosomes 6, 7, and 11. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012]

Canonical amino-acid sequenceUniProt

246 residues, UniProt reviewed canonical sequence.

>Q00059|TFAM
     1  MAFLRSMWGV LSALGRSGAE LCTGCGSRLR SPFSFVYLPR WFSSVLASCP KKPVSSYLRF
    61  SKEQLPIFKA QNPDAKTTEL IRRIAQRWRE LPDSKKKIYQ DAYRAEWQVY KEEISRFKEQ
   121  LTPSQIMSLE KEIMDKHLKR KAMTKKKELT LLGKPKRPRS AYNVYVAERF QEAKGDSPQE
   181  KLKTVKENWK NLSDSEKELY IQHAKEDETR YHNEMKSWEE QMIEVGRKDL LRRTIKKQRK
   241  YGAEEC

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against TFAM can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.46
Highest tissue expression
36 nTPM

Expression across tissuesHPA

Tissue

  • bone marrow: 36 nTPM
  • testis: 31 nTPM
  • lymph node: 26 nTPM
  • thymus: 23 nTPM
  • tonsil: 22 nTPM
  • liver: 21 nTPM

Single-cell type

  • late spermatids: 1,338 nCPM
  • early spermatids: 786 nCPM
  • erythrocyte progenitors: 144 nCPM
  • cytotrophoblasts: 121 nCPM
  • migrating cytotrophoblasts: 118 nCPM
  • gastric progenitor cells: 87 nCPM

Immune cell

  • NK-cell: 15 nTPM
  • plasmacytoid DC: 15 nTPM
  • memory B-cell: 13 nTPM
  • naive B-cell: 13 nTPM
  • naive CD4 T-cell: 12 nTPM
  • myeloid DC: 12 nTPM

Brain region

  • cerebellum: 25 nTPM
  • white matter: 20 nTPM
  • cerebral cortex: 20 nTPM
  • hypothalamus: 18 nTPM
  • spinal cord: 17 nTPM
  • choroid plexus: 17 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about TFAM.

Disease | AllUniProt

Conditions TFAM is implicated in, by any mechanism.

Disease | GeneticClinVar

2 pathogenic / likely-pathogenic of 105 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.61
gnomAD pLI
0.17
gnomAD missense Z
1.11
DepMap mean gene effect
-0.59
DepMap dependency class
common

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of TFAM in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads TFAM as an antibody target. Whether an autoantibody or antibody against TFAM could matter depends on whether native TFAM is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

TFAM is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label TFAM as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/TFAM. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...